Aimei Health Technology Co., Ltd.
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| General, administrative and operational costs | -$836K+21.5% | -$1.1M-3641.5% | -$28K |
| Loss from operations | -$836K+21.5% | -$1.1M-3641.5% | -$28K |
| Interest earned on cash held in trust | $1.9M-47.6% | $3.6M+1709.9% | $200K |
| Total other income, net | $1.9M-47.6% | $3.6M+1709.9% | $200K |
| NET INCOME | $1.1M-58.5% | $2.6M+1389.1% | $171K |
| Subject to Possible Redemption [Member] | |||
| Basic weighted average shares outstanding, ordinary shares | 2.1M+0.0% | 2.1M+38.2% | 1.5M |
| Diluted weighted average shares outstanding, ordinary shares | 2.1M+0.0% | 2.1M+38.2% | 1.5M |
| Basic net income per share, ordinary shares | $0.17-39.3% | $0.28+250.0% | $0.08 |
| Diluted net income per share, ordinary shares | $0.17-39.3% | $0.28+250.0% | $0.08 |
| Not Subject to Possible Redemption [Member] | |||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
No Form 4 transactions on record.
Informational purposes only, not investment advice.